Clinical Insights in Cancer Genome Interpretation
Añadir al calendario
- Tipo de evento
- Simposio
- Fecha
- 19 de noviembre de 2026
- Lugar del evento
- Barcelona Biomedical Research Park, Barcelona, Spain
- Dirigido a
- The symposium will be of interest to oncologists, pathologists, molecular biologists, bioinformaticians, translational researchers, clinical trial specialists, hospital leaders, patient representatives, policy makers, regulators, payers, and relevant industry stakeholders.
- Organizado por
- IRB (Institut de Recerca de Barcelona)
- Director/a
- Nuria Lopez Bigas
- Secretaría técnica
- CGI-Clinics Consortium
Información sobre el evento
IRB Barcelona and the CGI-Clinics project consortium invite you to attend free symposium on Clinical Insights in Cancer Genome Interpretation, exploring one of the most critical challenges in precision oncology: translating cancer genome data into meaningful clinical decisions.
Bringing together clinicians, molecular biologists, bioinformaticians, researchers and healthcare leaders, the symposium will examine how advances in genomic interpretation, molecular tumour boards and biomarker-driven clinical trials are shaping the future of personalised cancer care.
Key focus & objectives of the symposium:
- Genomic interpretation in Precision Oncology: Evaluate cutting-edge mutation interpretation pipelines, clinical decision support tools, and automated trial-matching platforms.
- Multidisciplinary Taskforce: Highlight best practices for Molecular Tumor Boards to streamline collaborative clinical decision-making.
- Translational Impact: Tackle the core challenges and opportunities in variant interpretation to empower healthcare professionals and directly improve patient outcomes.
By addressing the critical step of genomic interpretation from diverse clinical perspectives, this symposium equips the healthcare workforce to fully realize the promise of personalized cancer care.
This event is organised by the CGI-Clinics Consortium. The CGI-Clinics project has received funding from the European Union’s Horizon Europe programme under grant agreement CGI-Clinics 101057509.